SBIR-STTR Award

Novel Surgical Closure Device for Minimally Invasive Procedures
Award last edited on: 9/22/2015

Sponsored Program
SBIR
Awarding Agency
NSF
Total Award Amount
$1,363,999
Award Phase
2
Solicitation Topic Code
BC
Principal Investigator
Dan C Mazzucco

Company Information

ZSX Medical LLC

3401 Grays Ferry Avenue Building 176 Pennovation Center
Philadelphia, PA 19146
   (215) 271-2811
   info@zsxmedical.com
   www.zsxmedical.com
Location: Single
Congr. District: 03
County: Philadelphia

Phase I

Contract Number: 1315124
Start Date: 7/1/2013    Completed: 12/31/2013
Phase I year
2013
Phase I Amount
$180,000
This Small Business Innovation Research (SBIR) Phase I project develops a novel surgical closure system for closing internal incisions in endoscopy. The initial application is closing the vaginal cuff in laparoscopic hysterectomy. Sutures are typically used to close internal incisions in laparoscopic surgery. Throwing loops and tying knots are among the most difficult parts of laparoscopic procedures; these difficulties have slowed the adoption of minimally-invasive procedures, including laparoscopic hysterectomy. The system is a series of surgical clips that are designed to enable easy closure for difficult-to-access tissue, improving ease of use, speed, and quality of incision closure. The clips do not pierce tissue, but apply continuous compression to close the incision. The applicator tool pulls tissue into apposition for clip application, while reducing tissue handling, necrosis, ischemia, and the risk of infection.


The broader impact/commercial potential of this project is to develop, validate, and market the device across a broad spectrum of surgeries involving internal incisions (a total of 10 million procedures annually in the U.S. alone). This device has particular value in the rapidly-growing minimally-invasive surgery market, in which internal closure is made difficult by the small size of superficial incisions. These markets represent more than 6 million surgeries per year in the U.S., creating a domestic market potential of more than $2.5 billion for the device platform of closure devices. The closure device is designed to be simple and intuitive to use, which is critical in laparoscopic procedures. Initially, the closure device directly addresses a specific unmet clinical need: reducing both the technical demands of vaginal cuff closure during laparoscopic hysterectomy and the significant complications associated with the use of sutures in this procedure. There are approximately 300,000 laparoscopic hysterectomies performed in the U.S. annually. This number is growing at an estimated rate of 20% per year, and will represent a total annual addressable domestic market size at peak sales of $200 MM ($600 MM globally) for laparoscopic hysterectomy alone.

Phase II

Contract Number: 1430810
Start Date: 9/1/2014    Completed: 2/28/2017
Phase II year
2014
(last award dollars: 2017)
Phase II Amount
$1,183,999

The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase II project is as part of a broader plan to develop, validate, and market this new surgical device across a broad spectrum of surgeries involving internal incisions (a total of 10 million procedures annually in the U.S. alone). This technology has particular value in the rapidly-growing minimally-invasive surgery market, in which internal closure is made difficult by the small size of superficial incisions. These markets represent more than 6 million surgeries per year in the U.S., creating a domestic market potential of more than $2.5 billion for the platform of closure devices under development. Initially, the system directly addresses a specific unmet clinical need: reducing both the technical demands of internal closure during minimally-invasive hysterectomy and the significant complications associated with the use of sutures in this procedure. There were approximately 420,000 of these surgeries performed in the U.S. in 2013, representing more two-thirds of all U.S. hysterectomies. This fraction of hysterectomies performed in this manner is continuing to grow, and will represent a total annual addressable domestic market size at peak sales of $200 MM ($600 MM globally).The proposed project develops a novel surgical closure system for closing internal incisions in endoscopy. Our initial application is in laparoscopic (minimally-invasive) hysterectomy. Sutures are typically used to close internal incisions in laparoscopic surgery. Throwing loops and tying knots are among the most difficult parts of laparoscopic procedures; these difficulties have slowed the adoption of laparoscopic hysterectomy. In Phase II, the Technical Objectives are (1) to refine the closure system to meet the requirements of a minimum viable product; (2) to demonstrate safety and efficacy of the system in a large animal model of laparoscopic hysterectomy; and (3) to demonstrate efficacy of the system in laparoscopic hysterectomy in a cadaveric model. These objectives are designed to complete the evaluation of the performance of this novel closure system against product requirements identified by the surgical community and utilized in the design process.